NCT00005624View on ClinicalTrials.gov

CI-994 in Treating Patients With Advanced Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Multiple Myeloma
Interventions
DRUG

CI-994

CI-994 as outlined in treatment arm.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Parke-Davis

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00005624 - CI-994 in Treating Patients With Advanced Myeloma | Biotech Hunter | Biotech Hunter